Medrocan 500 mg Injection
Product Description
Medrocan 500 mg Injection contains Medroxyprogesterone Acetate (MPA), a synthetic progestin used in hormonal therapy and oncology-related treatments. It is administered by injection under strict medical supervision and is commonly prescribed in selected gynecological and cancer management protocols.
Composition
Active Ingredient: Medroxyprogesterone Acetate
Strength: 500 mg
Dosage Form: Injectable Solution
Route of Administration: Intramuscular (IM)
Therapeutic Uses
Treatment of advanced or recurrent hormone-dependent cancers (as prescribed by an oncologist), such as:
Endometrial cancer
Breast cancer (selected cases)
Hormonal therapy in specific gynecological conditions
Palliative management where progestin therapy is indicated
Mechanism of Action
Medroxyprogesterone Acetate works by:
Modifying hormonal balance
Inhibiting gonadotropin secretion
Exerting anti-estrogenic effects on hormone-sensitive tissues
This helps slow the growth of hormone-dependent tumors and regulate abnormal endometrial activity.
Key Benefits
High-strength 500 mg formulation for therapeutic protocols
Effective in hormone-responsive conditions
Long-acting progestin effect
Suitable for hospital and specialty clinical use
Dosage & Administration
Dosage and frequency are strictly as directed by a healthcare professional
Administered via deep intramuscular injection
Treatment schedule depends on indication and patient response
Possible Side Effects
Weight gain
Fluid retention
Irregular bleeding or spotting
Headache or dizziness
Injection site pain
(Side effects vary by patient and treatment duration.)
Storage Conditions
Store below 25°C
Protect from light
Do not freeze
Keep out of reach of children
Important Safety Information
Prescription-only injection
To be used only under specialist supervision
Not recommended during pregnancy
Regular medical monitoring is required during therapy
